Article

Personalized Medicine for Meningiomas: Drug Screening on Tumor Organoids Exposes…

medRxiv · 2024 · Jungwirth, G.; Cao, J.; Lotsch, C.; Warta, R.; Moustafa, M.; Knoll, M.; Yu, T.; Braun, V.; Jassowicz, L.; Dao Trong, P.; Younsi, A.; Scherer, M.; Bendszus, M.; Krieg, S. M.; von Deimling, A.; Debus, J.; Sahm, F.; Abdollahi, A.; Unterberg, A.; Herold-Mende, C.

Key facts

Title Personalized Medicine for Meningiomas: Drug Screening on Tumor Organoids Exposes Therapeutic Vulnerabilities to HDAC1/2i Panobinostat
First author Jungwirth, G.; Cao, J.; Lotsch, C.; Warta, R.; Moustafa, M.; Knoll, M.; Yu, T.; Braun, V.; Jassowicz, L.; Dao Trong, P.; Younsi, A.; Scherer, M.; Bendszus, M.; Krieg, S. M.; von Deimling, A.; Debus, J.; Sahm, F.; Abdollahi, A.; Unterberg, A.; Herold-Mende, C.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.11.26.625347
Devices mentioned K042884, K912666
Product codes mentioned JJH, JJQ, JQW, KPA, MYA, MXZ, NJT, NKF, PFF, PFT, LIQ

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature